Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma
- Study Title
- Efficacy of Inhaled Albuterol Spiromaxֲ® in Subjects With Persistent Asthma With Steady State Pharmacokinetics
- Teva Identifier
- ABS-AS-304
- ClinicalTrials.gov Identifier
- NCT01747629
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Placebo MDPI | Drug: Albuterol MDPI
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- 12/01/2012 - 11/01/2013
- Phase
- Phase 3
